Pretax income is the income that a company earns before paying income taxes. Illumina's pretax income for the
three
months ended in Dec. 2023 was $-167 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-1,116 Mil.
Illumina's pretax margin was -14.88%.
During the past 13 years, Illumina's highest Pretax Margin was 37.90%. The lowest was -94.59%. And the median was 25.19%.
Illumina Pre-Tax Income Historical Data
The historical data trend for Illumina's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Illumina's Pre-Tax Income
For the Diagnostics & Research subindustry, Illumina's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Illumina's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Illumina's Pre-Tax Income falls into.
Illumina Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Illumina's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1,116 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Illumina (NAS:ILMN) Pre-Tax Income Explanation
Illumina's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, Illumina's highest Pretax Margin was 37.90%. The lowest was -94.59%. And the median was 25.19%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Illumina Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Illumina's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ILMN has been successfully added to your 